In patients with asthma, stepping up to high-dose inhaled corticosteroids (ICS) was not effective in preventing future asthma exacerbations. Findings support the current Global Initiative for Asthma ...

WASHINGTON -- Adding dupilumab (Dupixent) to a medium-dose inhaled corticosteroid (ICS) routine helped lower asthma exacerbations and improved both lung function and asthma control, according to a ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window MILAN -- ...

A new study has found that using biologic therapy to reduce lung inflammation enabled 92% of people with severe asthma to reduce their dose of daily inhaled steroid without exacerbating their symptoms ...

Credit: Getty Images The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as many updated charts and tools. The 2025 update also ...

Please provide your email address to receive an email when new articles are posted on . Moving from a low-dose inhaled corticosteroid to a medium-dose inhaled corticosteroid plus a long-acting beta ...